These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16254139)

  • 1. Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2.
    Kitajima K; Tanaka M; Zheng J; Yen H; Sato A; Sugiyama D; Umehara H; Sakai E; Nakano T
    Blood; 2006 Mar; 107(5):1857-63. PubMed ID: 16254139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
    Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression.
    Kumano K; Chiba S; Shimizu K; Yamagata T; Hosoya N; Saito T; Takahashi T; Hamada Y; Hirai H
    Blood; 2001 Dec; 98(12):3283-9. PubMed ID: 11719365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines.
    Matsumura I; Kawasaki A; Tanaka H; Sonoyama J; Ezoe S; Minegishi N; Nakajima K; Yamamoto M; Kanakura Y
    Blood; 2000 Oct; 96(7):2440-50. PubMed ID: 11001896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system.
    Era T; Takagi T; Takahashi T; Bories JC; Nakano T
    Blood; 2000 Feb; 95(3):870-8. PubMed ID: 10648398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation.
    Tsang AP; Visvader JE; Turner CA; Fujiwara Y; Yu C; Weiss MJ; Crossley M; Orkin SH
    Cell; 1997 Jul; 90(1):109-19. PubMed ID: 9230307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors.
    Kitajima K; Masuhara M; Era T; Enver T; Nakano T
    EMBO J; 2002 Jun; 21(12):3060-9. PubMed ID: 12065419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem/progenitor cells.
    Fukushima K; Matsumura I; Ezoe S; Tokunaga M; Yasumi M; Satoh Y; Shibayama H; Tanaka H; Iwama A; Kanakura Y
    J Biol Chem; 2009 Mar; 284(12):7719-32. PubMed ID: 19147501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.
    Rekhtman N; Radparvar F; Evans T; Skoultchi AI
    Genes Dev; 1999 Jun; 13(11):1398-411. PubMed ID: 10364157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.
    Rekhtman N; Choe KS; Matushansky I; Murray S; Stopka T; Skoultchi AI
    Mol Cell Biol; 2003 Nov; 23(21):7460-74. PubMed ID: 14559995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation.
    Tsai FY; Orkin SH
    Blood; 1997 May; 89(10):3636-43. PubMed ID: 9160668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
    Walsh JC; DeKoter RP; Lee HJ; Smith ED; Lancki DW; Gurish MF; Friend DS; Stevens RL; Anastasi J; Singh H
    Immunity; 2002 Nov; 17(5):665-76. PubMed ID: 12433372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression.
    Visvader J; Adams JM
    Blood; 1993 Sep; 82(5):1493-501. PubMed ID: 7689871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.
    Vodyanik MA; Bork JA; Thomson JA; Slukvin II
    Blood; 2005 Jan; 105(2):617-26. PubMed ID: 15374881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
    Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
    Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin.
    Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E
    Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enforced expression of the GATA-3 transcription factor affects cell fate decisions in hematopoiesis.
    Chen D; Zhang G
    Exp Hematol; 2001 Aug; 29(8):971-80. PubMed ID: 11495703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
    Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
    Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.